|
MechanismCGRP antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date14 Sep 2018 |
|
MechanismVMAT2 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date03 Apr 2017 |
中国真实世界与亨廷顿病有关的舞蹈病患者中氘丁苯那嗪的有效性和安全性
[Translation] Efficacy and safety of deutetrabenazine in real-world Chinese patients with Huntington's disease-related chorea
主要目的:评估氘丁苯那嗪在中国真实世界治疗与亨廷顿病有关的舞蹈病成人患者的有效性。
次要目的:评估氘丁苯那嗪在中国真实世界治疗与亨廷顿病有关的舞蹈病成人患者的安全性。
[Translation] Primary objective: To evaluate the effectiveness of deutetrabenazine in treating adult patients with chorea associated with Huntington's disease in the real world of China.
Secondary objective: To evaluate the safety of deutetrabenazine in treating adult patients with chorea associated with Huntington's disease in the real world of China.
一项评价单次给药12 mg安泰坦®片剂在健康中国受试者中的氘丁苯那嗪及其活性代谢物的药代动力学特征的开放性、单剂量研究
[Translation] An open-label, single-dose study evaluating the pharmacokinetic profile of deutetrabenazine and its active metabolite in healthy Chinese subjects after a single 12 mg dose of Antaetan® tablets
评价健康中国男性和女性受试者餐后单次口服12 mg TEV-50717片剂后TEV-50717(母体药物)及其活性氘代代谢物α-二氢丁苯那嗪(α-HTBZ)和β-二氢丁苯那嗪(β-HTBZ)(总和及单个成分)的药代动力学特征。
[Translation] To evaluate the pharmacokinetic profiles of TEV-50717 (parent drug) and its active deuterated metabolites α-dihydrotetrabenazine (α-HTBZ) and β-dihydrotetrabenazine (β-HTBZ) (total and individual components) after a single oral dose of 12 mg TEV-50717 tablets in healthy Chinese male and female subjects after a meal.
中国真实世界中使用存达®(盐酸苯达莫司汀)治疗惰性非霍奇金淋巴瘤的有效性和安全性研究
[Translation] A real-world study of the efficacy and safety of Cundam® (bendamustine hydrochloride) in the treatment of indolent non-Hodgkin's lymphoma in China
中国真实世界中使用存达®(盐酸苯达莫司汀)治疗惰性非霍奇金淋巴瘤的有效性和安全性研究
[Translation] A real-world study of the efficacy and safety of Cundam® (bendamustine hydrochloride) in the treatment of indolent non-Hodgkin's lymphoma in China
100 Clinical Results associated with Teva Medical Information Consulting (Shanghai) Co., Ltd.
0 Patents (Medical) associated with Teva Medical Information Consulting (Shanghai) Co., Ltd.
100 Deals associated with Teva Medical Information Consulting (Shanghai) Co., Ltd.
100 Translational Medicine associated with Teva Medical Information Consulting (Shanghai) Co., Ltd.